NICE have stated that a clinician should offer patients over 80 years of age the same treatment as other patients over 55, taking account of any comorbidity and their existing burden of drug use
the guidance notes that patients over 80 years of age are poorly represented in clinical trials and the effectiveness of treatment in this group is less certain. However, it is reasonable to assume that older patients will receive worthwhile benefits from drug treatment, particularly in terms of reduced risk of stroke.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page